AVEM Labs LLC – FDA 483, Nov 22, 2022
AVEM LABS LLC, a stem cell manufacturer in Las Vegas, NV, was cited for multiple significant deficiencies during an FDA inspection from November 14-22, 2022. The observations primarily concern inadequate process validation, lack of stability data for expiration dates, insufficient aseptic process validation, poor record-keeping, and failures in donor eligibility determination and component control for their HCT/P products. These issues indicate a systemic lack of control over critical manufacturing and quality processes.
ID · 74e690cf-6a8f-4519-a585-f214dbeb2588
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.